Search Results 11-20 of 15010 for Retatrutide
Patients will be randomized to receive 8 mg/kg RoActemra/Actemra intravenously every 4 weeks or 50 mg etane rcept subcutaneously weekly. The anticipated time on ...
Know what claims about weight loss mean ... You might be surprised to learn that makers of dietary supplements rarely do clinical trials. That's part of the ...
The purpose of this study is to compare the effectiveness of axicabtagene ciloleucel versus standard of care therapy (SOCT), as measured by eventfree ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
Repotrectinib is used to treat ROS1-positive non-small cell lung cancer (NSCLC) that has spread within your chest or to other parts of the body. Your doctor ...
CLEOPATTRA: A Research Study To Look At The Effects Of Treatment With A Medicine Called Coramitug (NNC6019-0001) In People With Heart Failure Due To ...
Lutathera, the first FDA -approved peptide receptor radionuclide therapy, or PRRT , allows for precision targeting of NETs cells. Lutathera consists mainly of ...
This phase Ib/II clinical trial studies the side effects and best dose of venetoclax and how well it works when given together with vincristine liposomal in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.